Invention Grant
US08722687B2 Imidazo [1,2-A]pyridine derivatives as FGFR kinase inhibitors for use in therapy
有权
咪唑并[1,2-A]吡啶衍生物作为FGFR激酶抑制剂用于治疗
- Patent Title: Imidazo [1,2-A]pyridine derivatives as FGFR kinase inhibitors for use in therapy
- Patent Title (中): 咪唑并[1,2-A]吡啶衍生物作为FGFR激酶抑制剂用于治疗
-
Application No.: US13264596Application Date: 2010-04-15
-
Publication No.: US08722687B2Publication Date: 2014-05-13
- Inventor: Gordon Saxty , Valerio Berdini , Christopher William Murray , Eddy Jean Edgard Freyne , Yannick Aimé Eddy Ligny , Pascal Ghislain André Bonnet , Berthold Wroblowski , Alexandra Papanikos
- Applicant: Gordon Saxty , Valerio Berdini , Christopher William Murray , Eddy Jean Edgard Freyne , Yannick Aimé Eddy Ligny , Pascal Ghislain André Bonnet , Berthold Wroblowski , Alexandra Papanikos
- Applicant Address: GB Cambridge
- Assignee: Astex Therapeutics Ltd
- Current Assignee: Astex Therapeutics Ltd
- Current Assignee Address: GB Cambridge
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Priority: GB0906470.0 20090415
- International Application: PCT/GB2010/050618 WO 20100415
- International Announcement: WO2010/119285 WO 20101021
- Main IPC: C07D239/42
- IPC: C07D239/42 ; C07D401/04 ; A61K31/44 ; A01N43/42 ; C07D513/02 ; C07D515/02 ; C07D401/00 ; C07D403/00 ; C07D405/00 ; C07D409/00 ; C07D411/00 ; C07D413/00
![Imidazo [1,2-A]pyridine derivatives as FGFR kinase inhibitors for use in therapy](/abs-image/US/2014/05/13/US08722687B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to new bicyclic heterocyclyl derivatives of formula (I), to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Public/Granted literature
- US20120041000A1 IMIDAZO [1,2-A]PYRIDINE DERIVATIVES AS FGFR KINASE INHIBITORS FOR USE IN THERAPY Public/Granted day:2012-02-16
Information query